RWC Asset Management LLP trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 30.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 169,589 shares of the company’s stock after selling 72,596 shares during the period. RWC Asset Management LLP’s holdings in Colgate-Palmolive were worth $12,355,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also bought and sold shares of the stock. Vanguard Group Inc. raised its position in Colgate-Palmolive by 2.4% during the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after buying an additional 1,621,392 shares during the period. Renaissance Technologies LLC raised its position in Colgate-Palmolive by 42.4% during the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after buying an additional 2,903,800 shares during the period. Arrowstreet Capital Limited Partnership raised its position in Colgate-Palmolive by 25.3% during the second quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock valued at $508,111,000 after buying an additional 1,385,946 shares during the period. First Eagle Investment Management LLC raised its position in Colgate-Palmolive by 35.8% during the third quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock valued at $483,837,000 after buying an additional 1,750,417 shares during the period. Finally, Harding Loevner LP raised its position in Colgate-Palmolive by 92.0% during the third quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock valued at $176,329,000 after buying an additional 2,272,675 shares during the period. 72.86% of the stock is currently owned by hedge funds and other institutional investors.
In other news, insider Jennifer Daniels sold 902 shares of the stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the transaction, the insider now owns 37,788 shares of the company’s stock, valued at approximately $2,865,086.16. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CMO Mukul Deoras sold 7,500 shares of the stock in a transaction dated Friday, November 10th. The shares were sold at an average price of $73.28, for a total value of $549,600.00. Following the transaction, the chief marketing officer now directly owns 45,217 shares in the company, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. In the last three months, insiders have sold 181,950 shares of company stock worth $13,237,385. 1.02% of the stock is currently owned by insiders.
Several research analysts have weighed in on CL shares. Zacks Investment Research lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Jefferies Group reaffirmed a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Morgan Stanley dropped their target price on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 31st. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Finally, Deutsche Bank started coverage on Colgate-Palmolive in a research report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 target price on the stock. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $76.45.
Colgate-Palmolive (NYSE:CL) opened at $77.50 on Friday. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. The company has a market capitalization of $68,053.13, a PE ratio of 27.00, a PEG ratio of 3.24 and a beta of 0.80. Colgate-Palmolive has a fifty-two week low of $63.43 and a fifty-two week high of $77.91.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.73. The business had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.73 EPS. analysts expect that Colgate-Palmolive will post 2.87 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.06%. The ex-dividend date of this dividend is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is 61.78%.
TRADEMARK VIOLATION NOTICE: This article was first reported by TrueBlueTribune and is the property of of TrueBlueTribune. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.truebluetribune.com/2018/01/21/colgate-palmolive-cl-position-trimmed-by-rwc-asset-management-llp.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.